BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 25442346)

  • 21. MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer.
    Chen X; Chen S; Hang W; Huang H; Ma H
    Biomed Pharmacother; 2014 Jun; 68(5):589-95. PubMed ID: 24835695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
    Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
    Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer.
    Lei Z; Xu G; Wang L; Yang H; Liu X; Zhao J; Zhang HT
    FASEB J; 2014 Jun; 28(6):2696-704. PubMed ID: 24558198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CARMA3 Represses Metastasis Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis.
    Chang YW; Chiu CF; Lee KY; Hong CC; Wang YY; Cheng CC; Jan YH; Huang MS; Hsiao M; Ma JT; Su JL
    Am J Respir Crit Care Med; 2015 Jul; 192(1):64-75. PubMed ID: 25906011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358.
    Song SG; Yu HY; Ma YW; Zhang F; Xu XY
    Tumour Biol; 2016 Oct; 37(10):13705-13719. PubMed ID: 27476167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
    Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
    J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-15a-5p suppresses endometrial cancer cell growth via Wnt/β-catenin signaling pathway by inhibiting WNT3A.
    Wang ZM; Wan XH; Sang GY; Zhao JD; Zhu QY; Wang DM
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4810-4818. PubMed ID: 29164582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-223 enhances radiation sensitivity of U87MG cells in vitro and in vivo by targeting ataxia telangiectasia mutated.
    Liang L; Zhu J; Zaorsky NG; Deng Y; Wu X; Liu Y; Liu F; Cai G; Gu W; Shen L; Zhang Z
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):955-60. PubMed ID: 24606854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of NF-κB/miR-21/PTEN pathway sensitizes non-small cell lung cancer to cisplatin.
    Yang Z; Fang S; Di Y; Ying W; Tan Y; Gu W
    PLoS One; 2015; 10(3):e0121547. PubMed ID: 25799148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
    Tafsiri E; Darbouy M; Shadmehr MB; Zagryazhskaya A; Alizadeh J; Karimipoor M
    Tumour Biol; 2015 Mar; 36(3):1603-12. PubMed ID: 25384507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNA FAM201A involves in radioresistance of non-small-cell lung cancer by enhancing EGFR expression via miR-370.
    Liu AM; Zhu Y; Huang ZW; Lei L; Fu SZ; Chen Y
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5802-5814. PubMed ID: 31298332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene.
    Ke G; Liang L; Yang JM; Huang X; Han D; Huang S; Zhao Y; Zha R; He X; Wu X
    Oncogene; 2013 Jun; 32(25):3019-27. PubMed ID: 22847611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
    Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
    FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
    Yu QQ; Wu H; Huang X; Shen H; Shu YQ; Zhang B; Xiang CC; Yu SM; Guo RH; Chen L
    Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
    Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
    Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines.
    Kang J; Kim E; Kim W; Seong KM; Youn H; Kim JW; Kim J; Youn B
    J Biol Chem; 2013 Sep; 288(38):27343-27357. PubMed ID: 23902763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-183 potentially inhibits NF-κB1 expression by directly targeting its 3'-untranslated region.
    Sha F; Wu S; Zhang H; Guo X
    Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):991-6. PubMed ID: 25274328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10.
    Sun Y; Ai X; Shen S; Lu S
    Oncotarget; 2015 Apr; 6(10):8244-54. PubMed ID: 25749519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET.
    Zhou JY; Chen X; Zhao J; Bao Z; Chen X; Zhang P; Liu ZF; Zhou JY
    Cancer Lett; 2014 Sep; 351(2):265-71. PubMed ID: 24983493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.